Blog
RSS FeedPosted by Michael Wonder on 11 Nov 2019
Oncologist urges Kiwi lung cancer patients to be screened for access to free medication
11 November 2019 - An oncologist is urging hundreds of Kiwi lung cancer patients to contact their doctor to ensure ...
Posted by Michael Wonder on 11 Nov 2019
Charity to provide free EpiPens as PHARMAC still hasn't funded them
11 November 2019 - A funding boost is set to provide free EpiPens to 2500 children at risk of serious ...
Posted by Michael Wonder on 09 Nov 2019
NZ man Levi Holley selling his belongings to pay for brain cancer treatment
9 November 2019 - It started as a little nagging pain. It turned out to be an incurable brain tumour. ...
Posted by Michael Wonder on 09 Nov 2019
Lack of DHB testing means lung cancer patients could be missing out on life-prolonging drugs
9 November 2019 - New Zealanders with lung cancer could be missing out on a life-prolonging drug because of a ...
Posted by Michael Wonder on 08 Nov 2019
Health minister David Clark: postcode cancer care 'embarrassing'
9 November 2019 - Big differences in cancer care are "embarrassing" for the worst-performing District Health Boards and must be ...
Posted by Michael Wonder on 05 Nov 2019
New leukaemia medicine means three new cancer drugs funded this year
4 November 2019 - PHARMAC will fund a new leukaemia medicine, which will improve the quality of life for roughly ...
Posted by Michael Wonder on 05 Nov 2019
PHARMAC funding new leukaemia medicine
4 November 2019 - New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live ...
Posted by Michael Wonder on 03 Nov 2019
Hundreds of Kiwis battling leukaemia given hope with funding of new drug
4 November 2019 - Hundreds of Kiwis battling leukaemia cancer have been given hope, with PHARMAC today announcing funding for ...
Posted by Michael Wonder on 01 Nov 2019
Feilding epilepsy sufferer feared increased seizures following PHARMAC's drug brand switch
1 November 2019 - An epilepsy sufferer is urging others with the condition to boycott the Government's change in anti-epileptic ...
Posted by Michael Wonder on 31 Oct 2019
New Zealand Pharmaceutical Schedule - 1 November 2019
1 November 2019 - The November 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2019
Proposal to widen access to rituximab and change the funded brand for all funded indications excluding rheumatoid arthritis
31 October 2019 - PHARMAC is seeking feedback on a proposal to make changes to the funded brand of rituximab, ...
Posted by Michael Wonder on 30 Oct 2019
Growing medicines waiting list an international disgrace
29 October 2019 - The lack of transparency over timeliness and funding processes means New Zealand has a waiting list ...
Posted by Michael Wonder on 28 Oct 2019
Epilepsy sufferers not happy with PHARMAC drug change
28 October 2019 - PHARMAC has replaced its epilepsy drug - but some patients and families aren't happy about it. ...
Posted by Michael Wonder on 25 Oct 2019
Proposal to award sole supply for apomorphine hydrochloride
25 October 2019 - PHARMAC is proposing to make changes to the funding of apomorphine hydrochloride, a medicine used to ...
Posted by Michael Wonder on 24 Oct 2019
Mother fears daughter's death linked to PHARMAC's epilepsy drug switch
25 October 2019 - A woman who fears her daughter's death is linked to a change in her epilepsy medicine is ...